PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
July 19, 2011Journal of Clinical OncologyOpen Access

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

View Full Paper
Ask AI
Bookmark
Share

Authors

EPEdith A. PerezEREdward H. RomondVSVera J. Suman

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Perez et al. (2011) studied this question.

synapsesocial.com/papers/6a0cdf8c7aad2cc6fd1f5b77https://doi.org/10.1200/jco.2011.35.0868
View Full Paper
Ask AI
Bookmark
Share